Intelligent Bio Solutions Statistics
Total Valuation
INBS has a market cap or net worth of $5.70 million. The enterprise value is $2.52 million.
Important Dates
The next estimated earnings date is Friday, February 7, 2025, before market open.
| Earnings Date | Feb 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INBS has 4.39 million shares outstanding. The number of shares has increased by 2,038.60% in one year.
| Current Share Class | 4.39M |
| Shares Outstanding | 4.39M |
| Shares Change (YoY) | +2,038.60% |
| Shares Change (QoQ) | +25.34% |
| Owned by Insiders (%) | 2.16% |
| Owned by Institutions (%) | 5.90% |
| Float | 4.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.02 |
| Forward PS | 0.38 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 3.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.14 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -68.95 |
Financial Efficiency
Return on equity (ROE) is -290.94% and return on invested capital (ROIC) is -143.13%.
| Return on Equity (ROE) | -290.94% |
| Return on Assets (ROA) | -64.15% |
| Return on Capital (ROIC) | -143.13% |
| Revenue Per Employee | $63,759 |
| Profits Per Employee | -$208,344 |
| Employee Count | 50 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.93 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.28% in the last 52 weeks. The beta is 4.72, so INBS's price volatility has been higher than the market average.
| Beta (5Y) | 4.72 |
| 52-Week Price Change | -71.28% |
| 50-Day Moving Average | 1.53 |
| 200-Day Moving Average | 2.07 |
| Relative Strength Index (RSI) | 36.48 |
| Average Volume (20 Days) | 132,672 |
Short Selling Information
The latest short interest is 508,157, so 11.58% of the outstanding shares have been sold short.
| Short Interest | 508,157 |
| Short Previous Month | 564,618 |
| Short % of Shares Out | 11.58% |
| Short % of Float | 11.87% |
| Short Ratio (days to cover) | 1.25 |
Income Statement
In the last 12 months, INBS had revenue of $3.19 million and -$10.42 million in losses. Loss per share was -$4.17.
| Revenue | 3.19M |
| Gross Profit | 1.54M |
| Operating Income | -10.48M |
| Pretax Income | -10.03M |
| Net Income | -10.42M |
| EBITDA | -9.51M |
| EBIT | -10.48M |
| Loss Per Share | -$4.17 |
Full Income StatementBalance Sheet
The company has $3.99 million in cash and $809,281 in debt, giving a net cash position of $3.18 million or $0.72 per share.
| Cash & Cash Equivalents | 3.99M |
| Total Debt | 809,281 |
| Net Cash | 3.18M |
| Net Cash Per Share | $0.72 |
| Equity (Book Value) | 5.95M |
| Book Value Per Share | 1.39 |
| Working Capital | 800,112 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.65 million and capital expenditures -$221,426, giving a free cash flow of -$10.87 million.
| Operating Cash Flow | -10.65M |
| Capital Expenditures | -221,426 |
| Free Cash Flow | -10.87M |
| FCF Per Share | -$2.48 |
Full Cash Flow StatementMargins
| Gross Margin | 48.31% |
| Operating Margin | -328.80% |
| Pretax Margin | -327.90% |
| Profit Margin | n/a |
| EBITDA Margin | -298.42% |
| EBIT Margin | n/a |
| FCF Margin | n/a |